Skip Nav Destination
Limited-stage DLBCL: it’s patient selection
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study
Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes
Issue Archive
Table of Contents
BLOOD COMMENTARIES
CLINICAL TRIALS AND OBSERVATIONS
Limited-stage DLBCL: it’s patient selection
Clinical Trials & Observations
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma
Clinical Trials & Observations
Thierry Lamy,Gandhi Damaj,Pierre Soubeyran,Emmanuel Gyan,Guillaume Cartron,Krimo Bouabdallah,Rémy Gressin,Jérôme Cornillon,Anne Banos,Katell Le Du,Mohamed Benchalal,Marie-Pierre Moles,Steven Le Gouill,Joel Fleury,Pascal Godmer,Hervé Maisonneuve,Eric Deconinck,Roch Houot,Kamel Laribi,Jean Pierre Marolleau,Olivier Tournilhac,Bernard Branger,Anne Devillers,Jean Philippe Vuillez,Thierry Fest,Philippe Colombat,Valérie Costes,Vanessa Szablewski,Marie C. Béné,Vincent Delwail,on behalf of the LYSA Group
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
Clinical Trials & Observations
Nancy L. Bartlett,Brian A. Costello,Betsy R. LaPlant,Stephen M. Ansell,John G. Kuruvilla,Craig B. Reeder,Lim S. Thye,Daniel M. Anderson,Kilannin Krysiak,Cody Ramirez,Jing Qi,Barry A. Siegel,Malachi Griffith,Obi L. Griffith,Felicia Gomez,Todd A. Fehniger
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice
Jeannette Cany,Mieke W. H. Roeven,Janneke S. Hoogstad-van Evert,Willemijn Hobo,Frans Maas,Rosalia Franco Fernandez,Nicole M. A. Blijlevens,Walter J. van der Velden,Gerwin Huls,Joop H. Jansen,Nicolaas P. M. Schaap,Harry Dolstra
LYMPHOID NEOPLASIA
Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma
Clinical Trials & Observations
Keisuke Kataoka,Masako Iwanaga,Jun-ichirou Yasunaga,Yasunobu Nagata,Akira Kitanaka,Takuro Kameda,Makoto Yoshimitsu,Yuichi Shiraishi,Aiko Sato-Otsubo,Masashi Sanada,Kenichi Chiba,Hiroko Tanaka,Yotaro Ochi,Kosuke Aoki,Hiromichi Suzuki,Yusuke Shiozawa,Tetsuichi Yoshizato,Yusuke Sato,Kenichi Yoshida,Kisato Nosaka,Masakatsu Hishizawa,Hidehiro Itonaga,Yoshitaka Imaizumi,Wataru Munakata,Kotaro Shide,Yoko Kubuki,Tomonori Hidaka,Tsuyoshi Nakamaki,Ken Ishiyama,Shuichi Miyawaki,Ryohei Ishii,Osamu Nureki,Kensei Tobinai,Yasushi Miyazaki,Akifumi Takaori-Kondo,Tatsuhiro Shibata,Satoru Miyano,Kenji Ishitsuka,Atae Utsunomiya,Kazuya Shimoda,Masao Matsuoka,Toshiki Watanabe,Seishi Ogawa
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy
Anja Mottok,Vindi Jurinovic,Pedro Farinha,Andreas Rosenwald,Ellen Leich,German Ott,Heike Horn,Wolfram Klapper,Michael Boesl,Wolfgang Hiddemann,Christian Steidl,Joseph M. Connors,Laurie H. Sehn,Randy D. Gascoyne,Eva Hoster,Oliver Weigert,Robert Kridel
RED CELLS, IRON, AND ERYTHROPOIESIS
TRANSPLANTATION
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications
Antonio Russo,Giacomo Oliveira,Sofia Berglund,Raffaella Greco,Valentina Gambacorta,Nicoletta Cieri,Cristina Toffalori,Laura Zito,Francesca Lorentino,Simona Piemontese,Mara Morelli,Fabio Giglio,Andrea Assanelli,Maria Teresa Lupo Stanghellini,Chiara Bonini,Jacopo Peccatori,Fabio Ciceri,Leo Luznik,Luca Vago
LETTERS TO BLOOD
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study
Clinical Trials & Observations
Ali T. Taher,Zeynep Karakas,Elena Cassinerio,Noppadol Siritanaratkul,Antonis Kattamis,Aurelio Maggio,Stefano Rivella,Norbert Hollaender,Bruyère Mahuzier,Brian Gadbaw,Yesim Aydinok
Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes
Clinical Trials & Observations
BLOOD WORK
-
Cover Image
Cover Image
Color map obtained using the Barnes-Hut stochastic neighbor embedding bioinformatic algorithm for multidimensional single-cell analysis of a complex data set of immunophenotypic data, obtained upon analysis of a large panel of natural killer cell maturation markers in 5 healthy controls, 10 leukaphereses, and 10 patients analyzed at multiple time points after haploidentical hematopoietic stem cell transplantation. The map provides a visual representation of how samples in the data set cluster together. Coloring denotes the expression of the CD62L marker in individual samples, with red indicating high expression and blue indicating low expression. See the article by Russo et al on page 247.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement